top of page
Vaccination

PROJECTS

Two exciting projects have commenced in Autumn 2024.

REAL-SAIF

immune check point inhibitors.jfif

AIMS

  • Determine the real-world clinical outcomes of first-line ICI in advanced NSCLC to help support clinical decision making and discussions with patients around outcomes with these treatments.

  • Identify prognostic and predictive markers to first-line ICI in advanced NSCLC.  

bottom of page